Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Greentech Ventures Inc. currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being handled by 1 distinct examiner and is located within 1 distinct art unit. The company's current patent prosecution is characterized by a singular focus, with its active intellectual property efforts concentrated in 1 specific technical area.
The busiest examiner for the company is LIPPERT, JOHN WILLIAM, who is responsible for the 1 pending office action. Because the workload of LIPPERT, JOHN WILLIAM represents the entirety of the company's pending actions, the prosecution strategy is centralized. This allows for a focused and direct engagement with the specific requirements of the Biotechnology & Pharmaceuticals sector.
With 1 pending office action and 1 distinct art unit, the data indicates no current dispersion of the company's patent filings across different USPTO examination groups. The entire immediate workload is managed by a single examiner, which simplifies the management of the prosecution process. This concentration in the 1 distinct art unit suggests a very specific technological focus for the company's current patent applications.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LIPPERT, JOHN WILLIAM | 1 | 59.3% | +39.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18688910 | Methods and Compositions for Growing Plants | LIPPERT, JOHN WILLIAM | 36d overdue |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18688910 | Methods and Compositions for Growing Plants | LIPPERT, JOHN WILLIAM | 1615 | §103 | Final Rejection | 36d overdue | Pending | Mar 04, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGreentech Ventures Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
John William Lippert has the most, with 1 of Greentech Ventures Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.